Public-Private Partnerships Key Function Committee
Description: |
The mission of the Public-Private Partnerships Key Function Committee is to facilitate the implementation of partnerships and collaborations with industry, other academia and patient advocacy groups, and others within the consortium. This Key Function Committee aims (1) to share best practices across the CTSAs, (2) coordinate CTSA Consortium-wide exchange of information, (3) identify NIH programs and initiatives that help initiate collaborations and facilitate commercialization and (4) provide assistance with new or established partnerships to identify partners and partnership models. |
Accomplishments: |
CTSA-IP The CTSA Public-Private Partnership KFC is pleased to announce CTSA-IP, an IP aggregating web-based search engine at: http://www.rochesterctsa.org/ip/ The purpose of the website is to aggregate and market technologies from CTSA institutions as well as those of the National Institutes of Health, with the goal of enhancing research activity and private partnerships across the CTSA consortium. The website includes a text-searchable interface and regular, automatic updating with a standardized template to facilitate broad participation by CTSA consortium members. Currently, there are 15 CTSAs contributing information on their technologies to the site. CTSA institutions that wish to join should contact Mike Hazard at the University of Rochester (michael_hazard@urmc.rochester.edu). CTSA Pharmaceutical Assets Portal The CTSA Pharmaceutical Assets Portal "matches" researchers with investigational drugs and/or biologics that may be useful in elucidating disease mechanisms and/or new uses for clinical treatment. New Resource:
New Resources for Streamlining Clinical Trial and Material Transfer Agreements NCRR would like to bring to your attention some efforts now underway to streamline clinical trial and material transfer agreement negotiations between industry and academic research centers. The National Cancer Institute’s Standard Terms of Agreement for Research Trial (START) Clauses focus on company-sponsored and investigator-initiated clinical trial agreements. These contain model language on key concept areas including intellectual property, study data, indemnification, subject injury, confidentiality, and publication rights. For additional information, visit http://ccct.cancer.gov.
The Institute of Medicine offers similar resources at www.iom.edu/cta-mta, including:
H. Gilbert Smith, Ph.D., Office of Corporate Collaborations, Duke University School of Medicine, who is active in NCRR’s Clinical and Translational Science Award (CTSA) Consortium, has prepared a comparison of the NCI and IOM CTA and MTA provisions.
|
Public-Private Partnerships Groups: |
| Aggregating Intellectual Property and Resources |
| Agreements |
| Education |
Public-Private Partnerships Participants:
| Co-Chair(s) |
Ken Holroyd (Vanderbilt) Marc S. Malandro (Pittsburgh) |
| NIH Coordinator(s) |
Gregory L. Evans (NCI) Lili Portilla (NCRR) |
| PI Liaison(s) |
Eric Orwoll (OHSU) Eric J. Topol (Scripps) |
| Project Manager(s) | Mehrnama, Sum |
| Participation | Click to view |
| Next Meetings |
September 29, 2010 3:00 PM – 4:30 PM October 27, 2010 3:00 PM – 4:30 PM November 19, 2010 3:00 PM – 4:30 PM December 22, 2010 3:00 PM – 4:30 PM |
| Previous Meetings (2010) |
August 25, 2010
July 28, 2010 June 23, 2010 May 26, 2010 March 24, 2010 February 24, 2010 February 17, 2010 January 27, 2010 |
| Previous Meetings (2009) |
October 28, 2009
September 23, 2009 June 24, 2009 May 27, 2009 April 24, 2009 April 22, 2009 March 25, 2009 February 25, 2009 January 28, 2009 |
| Previous Meetings (2008) |
December 15, 2008
October 29, 2008 September 24, 2008 August 27, 2008 August 26, 2008 August 18, 2008 August 6, 2008 July 30, 2008 June 25, 2008 May 28, 2008 April 30, 2008 January 30, 2008 |
| Previous Meetings (2007) |
November 28, 2007
September 25, 2007 June 6, 2007 |